Search results for: 'dect intelligent pharma'
- Did you mean
- decis intelligent pharma
- d2cb intelligent pharma
- Related search terms
- pharmaceutical-industry-in-ghana-and-nigeria-18447
- pharmaceutical membrane filtration market analysis by product mce coated cellulose acetate nylon p1df membrane technique
- pharmaceutical R&D service market
- pharmaceutical industry market size of singapor
- intelligent transportation system bu market
-
14 Mar 2017  |  North America  |  Market Research
Game-changing Strategies of Leading US Pharma Companies
Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth
The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...
$1,500.00
Special Price $1,125.00 save 25 %
-
21 Dec 2022  |  North America  |  Market Research
Growth Opportunities and Innovative Use Cases for AI in Clinical Trials
Integrating Real-world Insights into Intelligent Platforms to Enable Patient-centric Trial Design
As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...
$2,450.00
Special Price $1,837.50 save 25 %
-
14 Feb 2017  |  North America  |  Market Research
Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market
Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...
$1,500.00
Special Price $1,125.00 save 25 %
-
11 Apr 2019  |  North America  |  Market Research
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...
$1,500.00
Special Price $1,125.00 save 25 %
-
19 Jun 2014  |  North America  |  Market Research
Pharmaceutical Industry in Ghana and Nigeria
A Ripe Business Opportunity for Big Pharma and Generic Pharma Companies
This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these ...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 May 2018  |  North America  |  Market Research
Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020
Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials
Clinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, t...
$3,000.00
Special Price $2,250.00 save 25 %
-
05 May 2020  |  North America  |  Frost Radar
FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020
Benchmarking Future Growth Potential
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2020  |  North America  |  Market Research
Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026
Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth
The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Sep 2022  |  North America  |  Market Research
AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics
Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade
Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Jan 2020  |  North America  |  Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00
Special Price $1,125.00 save 25 %